1. Home
  2. HUDI vs LYRA Comparison

HUDI vs LYRA Comparison

Compare HUDI & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUDI
  • LYRA
  • Stock Information
  • Founded
  • HUDI 1998
  • LYRA 2005
  • Country
  • HUDI China
  • LYRA United States
  • Employees
  • HUDI N/A
  • LYRA N/A
  • Industry
  • HUDI Steel/Iron Ore
  • LYRA Medical/Dental Instruments
  • Sector
  • HUDI Industrials
  • LYRA Health Care
  • Exchange
  • HUDI Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • HUDI 15.7M
  • LYRA 15.0M
  • IPO Year
  • HUDI 2021
  • LYRA 2020
  • Fundamental
  • Price
  • HUDI $1.12
  • LYRA $7.05
  • Analyst Decision
  • HUDI
  • LYRA Buy
  • Analyst Count
  • HUDI 0
  • LYRA 2
  • Target Price
  • HUDI N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • HUDI 19.2K
  • LYRA 28.3K
  • Earning Date
  • HUDI 08-22-2025
  • LYRA 08-12-2025
  • Dividend Yield
  • HUDI N/A
  • LYRA N/A
  • EPS Growth
  • HUDI N/A
  • LYRA N/A
  • EPS
  • HUDI N/A
  • LYRA N/A
  • Revenue
  • HUDI $66,566,370.00
  • LYRA $770,000.00
  • Revenue This Year
  • HUDI N/A
  • LYRA N/A
  • Revenue Next Year
  • HUDI N/A
  • LYRA $139.18
  • P/E Ratio
  • HUDI N/A
  • LYRA N/A
  • Revenue Growth
  • HUDI N/A
  • LYRA N/A
  • 52 Week Low
  • HUDI $1.06
  • LYRA $3.81
  • 52 Week High
  • HUDI $3.09
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • HUDI 39.35
  • LYRA 41.94
  • Support Level
  • HUDI $1.06
  • LYRA $6.51
  • Resistance Level
  • HUDI $1.17
  • LYRA $7.57
  • Average True Range (ATR)
  • HUDI 0.08
  • LYRA 0.55
  • MACD
  • HUDI 0.00
  • LYRA 0.14
  • Stochastic Oscillator
  • HUDI 28.57
  • LYRA 47.71

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: